JOURNAL OF INFECTIOUS DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2025-03-17 ms5000002977722150 来自上海

该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。
审稿周期在2-4周左右
是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。
需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以

20 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2025-03-17 ms4000000640854452 来自海南省

需要提交原始数据吗

26 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2023-09-06 ms1000000935651063 来自湖北省

偏重的研究方向：传染病
经验分享：这本杂志with editor多久啊，投了半个月了还是with editor

130 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2025-02-21 ms9000001487339035 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：乙肝
经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收

23 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

引言中文章的创新性如何体现？

172 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

引言需要写什么内容？

174 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2019-04-04 ms8480212230682571

审稿速度:6.0 | 投稿命中率:25.0
经验分享：reviwer 的意见比较详细，认真回答后已录用。

269 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2020-04-13 1248071em52(暂无昵称)

请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表::
的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表:
的确.最终出版时只能一个通讯.我已经在之前评论回复过了!

wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!

296 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2019-06-03 For you

这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?

314 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256521, encodeId=f2cf225652194, content=该期刊的收录范围非常广泛，涵盖了感染病学的各个领域，包括病毒学、细菌学、寄生虫学、真菌学等。无论是基础研究、临床研究还是流行病学研究，都可以投稿。 审稿周期在2-4周左右 是一本开放获取期刊，版面费在4300美元左右。但是具体费用会因文章类型和页数而有所浮动。 需要注意的是期刊“with editor”的时间比较长，要有足够的耐心才可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:43:03 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256410, encodeId=b1b4225641018, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c40d9442339, createdName=ms4000000640854452, createdTime=Mon Mar 17 10:20:02 CST 2025, time=2025-03-17, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2156407, encodeId=0624215640ed5, content=偏重的研究方向：传染病 经验分享：这本杂志with editor多久啊，投了半个月了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13545726588, createdName=ms1000000935651063, createdTime=Wed Sep 06 16:44:39 CST 2023, time=2023-09-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2252983, encodeId=c8702252983da, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乙肝 经验分享：投稿1周开始送审，外审两个月返修，给了两个月时间改文章，一个月就给返修回去了，提交后一个多星期接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc48770865, createdName=ms9000001487339035, createdTime=Fri Feb 21 15:26:24 CST 2025, time=2025-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1093398, encodeId=8ba0109339823, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093397, encodeId=3a12109339e08, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850642, encodeId=8aac85064270, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：reviwer 的意见比较详细，认真回答后已录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Thu Apr 04 02:40:14 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588753, encodeId=8784588e53d4, content=请问现在还是只允许一个通讯作者吗？指南里没看到，投稿快一个月，还是Review wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!wmw90 2017-09-03 00:00:00 发表: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, beContent=wmw90 2017-09-03 发表:: 的确.最终出版时只能一个通讯.我已经在之前评论回复过了!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b932492674, createdName=1248071em52(暂无昵称), createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571839, encodeId=e9435e1839dd, content=这个期刊是不是改过刊名？原来是不是叫Immunology and infectious diseases?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/bf0b0998ee22e7517060d91fd92e0c7e.jpg, createdBy=0a1e2036775, createdName=For you, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973130, encodeId=69969e3130eb, content=Jun 08, 2021提交的，10号送审的，期待审稿意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5f71952119, createdName=嗷大喵haha, createdTime=Sat Jun 12 18:49:14 CST 2021, time=2021-06-12, status=1, ipAttribution=)]

2021-06-12 嗷大喵haha

Jun 08, 2021提交的，10号送审的，期待审稿意见

209 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务